The hidden dangers of falsified and substandard medicines: Developing countries are most affected by the illegal trade

Judith Vorrath and Maike Voss

No 25/2019, SWP Comments from Stiftung Wissenschaft und Politik (SWP), German Institute for International and Security Affairs

Abstract: When talking about health risks in developing countries, many people think of events such as the Ebola virus epidemic in 2014 and 2015 in West Africa. The effects of trade in falsified and substandard medicines are far less known. Developing countries are particularly affected since they are easy targets for the illegal trade due to insufficient regulations and controls as well as limited access to health care. The health and (socio-)economic consequences are severe. Moreover, criminal net­works make large profits, usually without having to fear any significant punishment. The German government can push for a stronger focus on the issue at the World Health Assembly in May 2019. Germany's bilateral engagement should, above all, support developing countries in making drug supply chains safer.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/256567/1/2019C25.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:swpcom:252019

DOI: 10.18449/2019C25

Access Statistics for this paper

More papers in SWP Comments from Stiftung Wissenschaft und Politik (SWP), German Institute for International and Security Affairs
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().